secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2023-02-17T23:59:59+00:00
Accession:  0001493152-23-005435
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AgeX Therapeutics draws $1M under amended convertible note with Juvenescence; issues warrants for 801,924 shares
--------------------------------------------------------------------------------

- On Feb 15, 2023, drew $1M under Amended Secured Convertible Note with Juvenescence Limited.
- Up to $2M additional available until May 9, 2023; each draw limited to $1M and subject to Juvenescence's approval.
- Warrants for 801,924 shares at exercise price of $0.6235 per share issued in connection with the draw.
- Repayment date unchanged at Feb 14, 2024; note secured by security interests in AgeX assets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223005435/0001493152-23-005435-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223005435/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-005435

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer